Phreesia Inc (PHR)
22.61
-0.07
(-0.31%)
USD |
NYSE |
May 07, 16:00
22.61
0.00 (0.00%)
After-Hours: 20:00
Phreesia Cash from Operations (TTM): -32.38M for Jan. 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -32.38M |
October 31, 2023 | -45.20M |
July 31, 2023 | -59.64M |
April 30, 2023 | -70.15M |
January 31, 2023 | -90.12M |
October 31, 2022 | -112.20M |
July 31, 2022 | -115.98M |
April 30, 2022 | -102.87M |
January 31, 2022 | -74.71M |
October 31, 2021 | -32.65M |
July 31, 2021 | -8.792M |
Date | Value |
---|---|
April 30, 2021 | -4.486M |
January 31, 2021 | 2.89M |
October 31, 2020 | 0.087M |
July 31, 2020 | -2.279M |
April 30, 2020 | 0.696M |
January 31, 2020 | 0.826M |
October 31, 2019 | -4.246M |
July 31, 2019 | -0.4901M |
April 30, 2019 | 0.8263M |
January 31, 2019 | -2.13M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-115.98M
Minimum
Jul 2022
2.89M
Maximum
Jan 2021
-39.56M
Average
-32.38M
Median
Jan 2024
Cash from Operations (TTM) Benchmarks
Teladoc Health Inc | 345.78M |
American Shared Hospital Services | 5.718M |
Novo Integrated Sciences Inc | -4.952M |
Astrana Health Inc | 68.23M |
Cryo-Cell International Inc | 6.919M |